Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (311-320 of 325) with videos related to

Pageof 33
Sort By:
AIDS (London, England)|April 26, 2022
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in IndiaPooyan Kazemian, Delaney D Ding, Justine A Scott, et al.
AIDS and Behavior|February 6, 2021
Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic ProjectionsAnne M Neilan, Audrey C Bangs, Michael Hudgens, et al.
The New England Journal of Medicine|November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couplesRochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling studyKrishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2024
Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in TennesseeEthan D Borre, Aima A Ahonkhai, Kyu-Young Kevin Chi, et al.
The Lancet. Global Health|November 14, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling studyKrishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 14, 2022
Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention ProjectStephen C Resch, Julia H A Foote, Kathleen E Wirth, et al.
Journal of Virology|June 15, 2004
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infectionTodd M Allen, Marcus Altfeld, Xu G Yu, et al.
The Lancet. HIV|August 9, 2025
The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling studyEmily P Hyle, Linda-Gail Bekker, Suzanne M McCluskey, et al.
JMIR Research Protocols|April 17, 2019
Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161)Anne M Neilan, Kunjal Patel, Allison L Agwu, et al.
Pageof 33

Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
AIDS (London, England)|April 26, 2022
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in IndiaPooyan Kazemian, Delaney D Ding, Justine A Scott, et al.
AIDS and Behavior|February 6, 2021
Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic ProjectionsAnne M Neilan, Audrey C Bangs, Michael Hudgens, et al.
The New England Journal of Medicine|November 1, 2013
Cost-effectiveness of HIV treatment as prevention in serodiscordant couplesRochelle P Walensky, Eric L Ross, Nagalingeswaran Kumarasamy, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling studyKrishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2024
Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in TennesseeEthan D Borre, Aima A Ahonkhai, Kyu-Young Kevin Chi, et al.
The Lancet. Global Health|November 14, 2020
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling studyKrishna P Reddy, Fatma M Shebl, Julia H A Foote, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 14, 2022
Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention ProjectStephen C Resch, Julia H A Foote, Kathleen E Wirth, et al.
Journal of Virology|June 15, 2004
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infectionTodd M Allen, Marcus Altfeld, Xu G Yu, et al.
The Lancet. HIV|August 9, 2025
The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling studyEmily P Hyle, Linda-Gail Bekker, Suzanne M McCluskey, et al.
JMIR Research Protocols|April 17, 2019
Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161)Anne M Neilan, Kunjal Patel, Allison L Agwu, et al.
Pageof 33